Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
145.00
-3.26 (-2.20%)
At close: Dec 1, 2025, 4:00 PM EST
144.65
-0.35 (-0.24%)
After-hours: Dec 1, 2025, 7:59 PM EST
Molina Healthcare Market Cap
Molina Healthcare has a market cap or net worth of $7.45 billion as of December 1, 2025. Its market cap has decreased by -59.14% in one year.
Market Cap
7.45B
Enterprise Value
7.08B
1-Year Change
-59.14%
Ranking
Category
Stock Price
$145.00
Market Cap Chart
Since July 2, 2003, Molina Healthcare's market cap has increased from $496.00M to $7.45B, an increase of 1,402.62%. That is a compound annual growth rate of 12.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 7.62B | -54.23% |
| Dec 31, 2024 | 16.65B | -20.97% |
| Dec 29, 2023 | 21.06B | 9.23% |
| Dec 30, 2022 | 19.28B | 3.82% |
| Dec 31, 2021 | 18.58B | 47.29% |
| Dec 31, 2020 | 12.61B | 48.24% |
| Dec 31, 2019 | 8.51B | 17.34% |
| Dec 31, 2018 | 7.25B | 65.62% |
| Dec 29, 2017 | 4.38B | 42.00% |
| Dec 30, 2016 | 3.08B | -8.57% |
| Dec 31, 2015 | 3.37B | 30.17% |
| Dec 31, 2014 | 2.59B | 62.92% |
| Dec 31, 2013 | 1.59B | 26.16% |
| Dec 31, 2012 | 1.26B | 23.53% |
| Dec 30, 2011 | 1.02B | 21.16% |
| Dec 31, 2010 | 842.20M | 44.14% |
| Dec 31, 2009 | 584.30M | 23.22% |
| Dec 31, 2008 | 474.20M | -56.80% |
| Dec 31, 2007 | 1.10B | 20.27% |
| Dec 29, 2006 | 912.60M | 23.37% |
| Dec 30, 2005 | 739.70M | -42.04% |
| Dec 31, 2004 | 1.28B | 100.19% |
| Dec 31, 2003 | 637.50M | 28.53% |
| Jul 2, 2003 | 496.00M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |